1. Home
  2. NTIC vs ATYR Comparison

NTIC vs ATYR Comparison

Compare NTIC & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

HOLD

Current Price

$8.00

Market Cap

83.1M

Sector

Industrials

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.83

Market Cap

77.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTIC
ATYR
Founded
1970
2005
Country
United States
United States
Employees
N/A
58
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.1M
77.0M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NTIC
ATYR
Price
$8.00
$0.83
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
12.2K
788.8K
Earning Date
04-09-2026
05-01-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$84,234,474.00
N/A
Revenue This Year
$12.49
N/A
Revenue Next Year
$7.64
N/A
P/E Ratio
$402.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.10
$0.64
52 Week High
$10.03
$7.29

Technical Indicators

Market Signals
Indicator
NTIC
ATYR
Relative Strength Index (RSI) 41.98 52.37
Support Level $7.91 $0.68
Resistance Level $8.25 $0.86
Average True Range (ATR) 0.18 0.05
MACD 0.01 0.00
Stochastic Oscillator 16.67 67.67

Price Performance

Historical Comparison
NTIC
ATYR

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: